8-K: Scorpius Holdings Announces 1-for-20 Reverse Stock Split to Maintain NYSE American Listing Compliance

Scorpius Holdings has approved a 1-for-20 reverse stock split to increase its share price and maintain compliance with NYSE American listing requirements.

Summary

• Scorpius Holdings' stockholders approved a reverse stock split at a special meeting on January 16, 2025.
• The board of directors subsequently approved a 1-for-20 reverse stock split.
• The reverse stock split will be effective on January 21, 2025, at 12:01 a.m. Eastern Time.
• The number of outstanding shares will decrease from approximately 5.8 million to approximately 0.3 million.
• Fractional shares will not be issued; instead, shareholders will receive a cash payment based on the average closing price of the stock for the ten days preceding the effective date.
• The trading symbol will remain SCPX, but the CUSIP number will change to 42237K607.

Sentiment

Score: 6

Explanation: The document is neutral to slightly negative. While the reverse stock split is a necessary action to maintain listing compliance, it can be perceived negatively by investors. The company is taking proactive steps to address the issue, but the long-term impact is uncertain.

Positives

• The reverse stock split is a proactive measure to maintain compliance with NYSE American listing requirements.
• The company is providing cash payments for fractional shares, ensuring fair treatment for all shareholders.
• The reverse stock split will not change the percentage ownership of shareholders, except for those receiving cash for fractional shares.

Negatives

• The reverse stock split reduces the number of outstanding shares, which may be perceived negatively by some investors.
• Shareholders holding fewer than 20 shares will be eliminated as a result of the cash payment in lieu of fractional shares.

Risks

• The reverse stock split may not be effective in increasing the share price long-term.
• The company's ability to maintain its listing on the NYSE American is not guaranteed.
• The company's future performance is subject to various factors, as outlined in their SEC filings.

Future Outlook

The company intends to maintain compliance with the NYSE American listing requirements. The company will continue to monitor its share price and may take further actions as needed.

Management Comments

• The Board of Directors approved the reverse stock split to increase the selling price of the Company's Common Stock in order to maintain compliance with the requirements and policies of the NYSE American.
• The reverse stock split will not affect any stockholders percentage ownership interests in the Company, except those stockholders who would have otherwise received fractional shares.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low share prices. This action is not unique to Scorpius and is often seen in the biotech and pharmaceutical sectors.

Comparison to Industry Standards

• Reverse stock splits are a common mechanism used by companies to regain compliance with exchange listing requirements, particularly when share prices fall below minimum thresholds.
• Many companies in the biotech and pharmaceutical industries have used reverse stock splits to avoid delisting, including companies such as Agenus Inc. and Ocugen Inc.
• The 1-for-20 ratio is within the typical range for reverse stock splits, which can range from 1-for-2 to 1-for-100, depending on the specific circumstances of the company.

Stakeholder Impact

• Shareholders will experience a reduction in the number of shares they own, but their percentage ownership will remain the same, except for those receiving cash for fractional shares.
• Shareholders holding fewer than 20 shares will be eliminated as a result of the cash payment in lieu of fractional shares.
• The company aims to maintain its listing on the NYSE American, which is important for investor confidence.

Next Steps

• The company will file the Charter Amendment with the Secretary of State of Delaware on January 17, 2025.
• The reverse stock split will become effective on January 21, 2025, at 12:01 a.m. Eastern Time.
• The company's stock will begin trading on a post-split basis on January 21, 2025.

Key Dates

Keywords

reverse stock split, NYSE American, stockholders, common stock, listing compliance, share price, CUSIP, fractional shares